We are at risk of being a takeover target for Amylyx given their recent news and PAA market cap. They have plenty of cash but also to avoid deleting it may be scrip + cash offer who knows. Mike was also recently over having a chat with the team, so we would definitely be a raid target. ODD in the coming month could be a catalyst as we sit at only around $45m USD.
Could be wrong but we need a partner / deal to bring this back to life, with cash for P2 and planning trial in H2 costing $20-$30m. Unless a new team can pull a rabbit out of a hat. Best of luck!
0000950170-24-056269 | 10-Q | Amylyx Pharmaceuticals, Inc.
0
Ann: Board Changes, page-218
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.22M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.5¢ | $92.37K | 466.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 602116 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 188391 | 3 |
View Market Depth
| Last trade - 11.58am 30/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |